Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D001104 |
Arbutin |
Arbutin results in decreased expression of ARHGEF2 mRNA | decreases expression | 17103032
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ARHGEF2 mRNA | affects cotreatment|increases expression | 18164116
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of ARHGEF2 mRNA | decreases expression | 20678512
|
C057862 |
cyanoginosin LR |
cyanoginosin LR results in increased expression of ARHGEF2 mRNA | increases expression | 17654400
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of ARHGEF2 mRNA | increases expression | 20106945
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ARHGEF2 mRNA | affects cotreatment|increases expression | 18164116
|
C008493 |
methylselenic acid |
methylselenic acid results in increased expression of ARHGEF2 mRNA | increases expression | 18548127
|
C496197 |
trans-10,cis-12-conjugated linoleic acid |
trans-10,cis-12-conjugated linoleic acid results in increased expression of ARHGEF2 mRNA | increases expression | 17951470
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of ARHGEF2 mRNA | increases expression | 16054129
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
7.25 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
7.25 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
4.18 | 19061943 19052882 17620307 16434500 17162532 18056438 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.78 | 15955085 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.19 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.30 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.39 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.64 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.81 | 16197459 16206674 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.07 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
1.93 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.93 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.93 | 16873071 16166294 16443354 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.88 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.48 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
3.12 | 19052882 20007298 19539802 18506893 16569478 17138121 18210153 11831363 20727157 19171122 19701751 16779866 20214788 17978847 16935385 19519916 3084413 20524982 19208518 17761372 18393292 17173139 16328049 20084675 16502159 19822196 18788625 16288022 17162532 21159647 18056438 18785209 19418558 16807293 18971187 19394651 10672840 18665156 19383236 16540662 16878318 17428255 20512989 16681979 20101231 17055752 3581430 19919837 19335982 16830150 10737359 20432363 16698587 19107877 18494052 20935162 18691550 20514400 18978308 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.12 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.27 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.34 | 16096774 16051514 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.20 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.06 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
7.06 | 17174075 2727394 7505956 21159647 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.88 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.87 | 19052882 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.06 | 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.48 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.74 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.96 | 17035595 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.83 | 9211117 16925845 9125849 17551590 14991402 10589399 9664655 8800419 9142499 9224671 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.23 | 20387270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
cyanoginosin LR |
4.51 | 17654400 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
4.51 | 19107877 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.78 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.23 | 16569247 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.44 | 16302075 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.73 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.41 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
8.41 | 21071580 20387270 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.57 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
9.57 | 17994277 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.50 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.13 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.32 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.48 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.99 | 9664655 14991402 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.71 | 15720958 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.37 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.83 | 16778211 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.16 | 10903974 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.47 | 18785209 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.41 | 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.02 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.11 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.76 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.44 | 8314463 18776723 10903974 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.90 | 12371664 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.86 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.90 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.10 | 19850784 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.28 | 16935935 17368321 19029980 12679006 17301526 16140955 17294898 17506722 17361223 16766008 19642359 15748426 19035177 16331271 16788101 17217047 16891316 17107899 19225113 17712046 16823087 9834237 17649720 17339181 19075265 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.45 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.93 | 18522880 18407596 20032147 18665156 19638242 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
1.81 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.14 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
4.99 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
4.99 | 18648771 19090486 19426721 19996281 18977376 19833225 19294768 19642983 19690152 2862719 18644402 19255062 15175105 15885732 19254457 20434301 20101389 18978307 18754104 19551842 19499222 21167192 12771043 20583210 21047994 19256749 20405173 20501860 20452335 2422723 10737359 21071580 19427195 20118626 19073162 9163691 19638242 19850985 20492335 19812893 12112319 20137499 21278145 16942905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
6.54 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
6.54 | 19126423 18775883 18253720 19009564 3124819 2563599 18079962 19539802 18164116 19004024 18544905 19519916 18308698 9362446 18282651 18093689 16842330 17174075 17942915 17854601 21159647 16267830 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
1.76 | 21163286 20512841 20970405 6695378 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.85 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.96 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.68 | 16940565 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.11 | 16801185 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.19 | 17596541 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.64 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.49 | 16946489 16594593 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.76 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.47 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
10.60 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
10.60 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.18 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.51 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.44 | 20387270 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.27 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.40 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.07 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.46 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.46 | 15976015 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.56 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.56 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
4.24 | 10548101 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.41 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.52 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
3.52 | 16205645 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.82 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.29 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.08 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
5.07 | 10548101 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.32 | 16283617 16116481 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.69 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.46 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.46 | 17261132 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.27 | 16045194 16684133 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.69 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.69 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.98 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.34 | 16040207 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.87 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.33 | 14652134 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.93 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.30 | 1336536 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.29 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.15 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.76 | 17120751 |